Access cutting-edge melanoma treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
The researchers are doing this study to find out whether the study vaccines, IO102/IO103, given in combination with the standard-of-care drug combination, nivolumab and relatlimab, is a safe and effective treatment for people with untreated, unresectable melanoma.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this melanoma clinical trial in Hartford, CT
If you're searching for melanoma treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.